HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myeloid Cell-Restricted Insulin/IGF-1 Receptor Deficiency Protects against Skin Inflammation.

Abstract
Myeloid cells are key regulators of tissue homeostasis and disease. Alterations in cell-autonomous insulin/IGF-1 signaling in myeloid cells have recently been implicated in the development of systemic inflammation and insulin-resistant diabetes mellitus type 2 (DM). Impaired wound healing and inflammatory skin diseases are frequent DM-associated skin pathologies, yet the underlying mechanisms are elusive. In this study, we investigated whether myeloid cell-restricted IR/IGF-1R signaling provides a pathophysiologic link between systemic insulin resistance and the development of cutaneous inflammation. Therefore, we generated mice lacking both the insulin and IGF-1 receptor in myeloid cells (IR/IGF-1R(MKO)). Whereas the kinetics of wound closure following acute skin injury was similar in control and IR/IGF-1R(MKO) mice, in two different conditions of dermatitis either induced by repetitive topical applications of the detergent SDS or by high-dose UV B radiation, IR/IGF-1R(MKO) mice were protected from inflammation, whereas controls developed severe skin dermatitis. Notably, whereas during the early phase in both inflammatory conditions the induction of epidermal proinflammatory cytokine expression was similar in control and IR/IGF-1R(MKO) mice, during the late stage, epidermal cytokine expression was sustained in controls but virtually abrogated in IR/IGF-1R(MKO) mice. This distinct kinetic of epidermal cytokine expression was paralleled by proinflammatory macrophage activation in controls and a noninflammatory phenotype in mutants. Collectively, our findings provide evidence for a proinflammatory IR/IGF-1R-dependent pathway in myeloid cells that plays a critical role in the dynamics of an epidermal-dermal cross-talk in cutaneous inflammatory responses, and may add to the mechanistic understanding of diseases associated with disturbances in myeloid cell IR/IGF-1R signaling, including DM.
AuthorsJana Knuever, Sebastian Willenborg, Xiaolei Ding, Mehmet D Akyüz, Linda Partridge, Carien M Niessen, Jens C Brüning, Sabine A Eming
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 195 Issue 11 Pg. 5296-5308 (Dec 01 2015) ISSN: 1550-6606 [Electronic] United States
PMID26519530 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 by The American Association of Immunologists, Inc.
Chemical References
  • Cytokines
  • Sodium Dodecyl Sulfate
  • Receptor, IGF Type 1
  • Receptor, Insulin
Topics
  • Animals
  • Cells, Cultured
  • Cytokines (metabolism)
  • Dermatitis (genetics, immunology)
  • Diabetes Mellitus, Type 2 (genetics, immunology)
  • Inflammation (genetics, immunology)
  • Insulin Resistance (genetics, immunology)
  • Macrophage Activation (immunology)
  • Macrophages (immunology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Receptor, IGF Type 1 (genetics)
  • Receptor, Insulin (genetics)
  • Signal Transduction (immunology)
  • Skin (immunology)
  • Sodium Dodecyl Sulfate (adverse effects)
  • Ultraviolet Rays (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: